Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;52(12):e782-e787.
doi: 10.1161/STROKEAHA.121.035220. Epub 2021 Oct 21.

Geographic and Regional Variability in Racial and Ethnic Disparities in Stroke Thrombolysis in the United States

Affiliations

Geographic and Regional Variability in Racial and Ethnic Disparities in Stroke Thrombolysis in the United States

Deji Suolang et al. Stroke. 2021 Dec.

Abstract

Background and purpose: Intravenous thrombolysis (IVT) after ischemic stroke is underutilized in racially/ethnically minoritized groups. We aimed to determine the regional and geographic variability in racial/ethnic IVT disparities in the United States.

Methods: Acute ischemic stroke admissions between 2012 and 2018 were identified in the National Inpatient Sample. Multivariable logistic regression was used to test the association between IVT and race/ethnicity, stratified by geographic region and controlling for demographic, clinical, and hospital characteristics.

Results: Of the 545 509 included cases, 47 031 (8.6%) received IVT. Racially/ethnically minoritized groups had significantly lower adjusted odds of IVT compared with White people in the South Atlantic region (odds ratio [OR], 0.86 [95% CI, 0.82-0.91]), the East North Central region (OR, 0.91 [95% CI, 0.85-0.97]) and the Pacific region (OR, 0.90 [95% CI, 0.85-0.96]). In the South Atlantic region, IVT use in racial/ethnic minority groups was below the national average of all racial/ethnic minority patients (P=0.002). Compared with White patients, Black patients had lower odds of IVT in the Middle Atlantic region (OR, 0.84 [95% CI, 0.78-0.91]), the South Atlantic region (OR, 0.78 [95% CI, 0.74-0.82]), and the East North Central region (OR, 0.86 [95% CI, 0.79-0.93]). In the South Atlantic region, this difference was below the national average for Black people (P<0.001). Hispanic patients had significantly lower use of IVT only in the Pacific region (OR, 0.92 [95% CI, 0.85-0.99]), while Asian/Pacific Islander patients had lower odds of IVT in the Mountain (OR, 0.76 [95% CI, 0.59-0.98]) and Pacific region (OR, 0.89 [95% CI, 0.82-0.97]).

Conclusions: Racial/ethnic disparities in IVT use in the United States vary by region. Geographic hotspots of lower IVT use in racially/ethnically minoritized groups are the South Atlantic region, driven predominantly by lower use of IVT in Black patients, and the East North Central and Pacific regions.

Keywords: African Americans; ethnic groups; geographic locations; minority groups; stroke; thrombolytic therapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Regional variability in IVT disparities for all racial/ethnic minority groups.
IVT use in racial/ethnic minority groups compared to White people stratified by geographic region (A); and color-coded U.S. map representing IVT treatment differences in racial/ethnic minority groups compared to White people by geographic region (B). Green areas indicate no disparity, i.e. no IVT underutilization compared to White people (OR>1); green-yellow checkered areas indicate no statistically significant disparity (OR<1, but 95% CI including 1); yellow areas indicate a disparity (i.e. lower use) comparable to the national average (OR and 95% CI <1, but not significantly below the national average); and the red areas indicate a disparity below the national average (OR and 95% CI <1, and statistically significantly below the national average).
Figure 2.
Figure 2.. Regional variability in IVT disparities by race/ethnicity.
IVT use in Black (A), Hispanic (C), and Asian/PI (E) patients compared to White people stratified by geographic region, and corresponding color-coded U.S. maps (B, D, and F, respectively).

References

    1. Aparicio HJ, Carr BG, Kasner SE, Kallan MJ, Albright KC, Kleindorfer DO, Mullen MT. Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers. J Am Heart Assoc. 2015;4:e001877. doi: 10.1161/JAHA.115.001877 - DOI - PMC - PubMed
    1. Faigle R, Urrutia VC, Cooper LA, Gottesman RF. Racial Differences in Utilization of Life-Sustaining vs Curative Inpatient Procedures After Stroke. JAMA Neurol. 2016;73:1151–1153. doi: 10.1001/jamaneurol.2016.1914 - DOI - PMC - PubMed
    1. Hsia AW, Edwards DF, Morgenstern LB, Wing JJ, Brown NC, Coles R, Loftin S, Wein A, Koslosky SS, Fatima S, et al. Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study. Stroke. 2011;42:2217–2221. doi: 10.1161/STROKEAHA.111.613828 - DOI - PMC - PubMed
    1. Sacco RL, Gardener H, Wang K, Dong C, Ciliberti-Vargas MA, Gutierrez CM, Asdaghi N, Burgin WS, Carrasquillo O, Garcia-Rivera EJ, et al. Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study. J Am Heart Assoc. 2017;6. doi: 10.1161/JAHA.116.004073 - DOI - PMC - PubMed
    1. Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, Zhao X, Peterson E, Fonarow GC. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492–1501. doi: 10.1161/CIRCULATIONAHA.109.881490 - DOI - PubMed

Publication types

MeSH terms